Feasibility of Estimating the Prevalence and Management of Stage 4 CKD the Gard, France

Study acronym: MRC-Gard
StatusRecruiting
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 1 year 11 months later Dec 2025 → Dec 2027
See other at-risk trials from Centre Hospitalier Universitaire de Nīmes

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion pushed from Dec 2025 to Dec 2027 Show 4 more changesShow less
    • Primary endpoints: details revised at 2 of 2 entries
    • Secondary endpoints: details revised at 3 of 3 entries
    • Site details revised at 1 of 4 sites
    • Eligibility criteria expanded, about 1 word
  2. Re-verified, no change to tracked fieldsv11
  3. Primary and study completion dates: Dec 2022 to Dec 2025v10
  4. Primary and study completion dates: Dec 2020 to Dec 2022v9
  5. Primary and study completion dates: Apr 2020 to Dec 2020v8
Show 6 earlier versionsHide 6 earlier versions
  1. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Oct 2019 to Jan 1, 2019
    • Site details revised at 4 of 4 sites
    v7
  2. Primary and study completion dates: Apr 2019 to Apr 2020
    • Start date: Oct 2018 to Oct 2019
    v6
  3. Start date: Jun 2018 to Oct 2018
    • Primary and study completion dates: Dec 2018 to Apr 2019
    v5
  4. Start date: Mar 2018 to Jun 2018v4
  5. Start date: Nov 2017 to Mar 2018v3
  6. Primary and study completion dates: Dec 2017 to Dec 2018
    • Start date: Jan 2017 to Nov 2017
    v2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
The main objective of this study is to evaluate the feasibility of estimating the prevalence of stage 4 and 5 chronic kidney disease in the Gard department of France from data obtained via laboratory databases. To verifiy if the demand for care thus authenticated by laboratory tests is adapted to nephrology care delivery, as recommended by the French High Authority of Health (HAS), laboratory data will be compared with those of patients seen by nephrologists in the department.
Trial Details
NCT Number NCT02938611
Lead Sponsor Centre Hospitalier Universitaire de Nīmes
Conditions
(from sponsor)		 Renal Insufficiency, Chronic
Related terms Renal Insufficiency, Chronic
Enrollment 3,375 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov